XML 48 R38.htm IDEA: XBRL DOCUMENT v3.23.2
Detail of Certain Accounts (Tables)
6 Months Ended
Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Cash and Cash Equivalents Amounts related to cash and cash equivalents held by consolidated or proportionately consolidated joint ventures and the captive insurance company, which are included in Quanta’s total cash and cash equivalents balances, were as follows (in thousands):
 June 30, 2023December 31, 2022
Cash and cash equivalents held by domestic joint ventures$27,836 $14,291 
Cash and cash equivalents held by foreign joint ventures4,854 6,277 
Total cash and cash equivalents held by joint ventures32,690 20,568 
Cash and cash equivalents held by captive insurance company33,663 35,085 
Cash and cash equivalents not held by joint ventures or captive insurance company295,613 372,852 
Total cash and cash equivalents$361,966 $428,505 
Accounts Payable and Accrued Expenses
Accounts payable and accrued expenses consisted of the following (in thousands):
 June 30, 2023December 31, 2022
Accounts payable, trade$1,672,778 $1,302,086 
Accrued compensation and related expenses469,661 469,048 
Other accrued expenses374,469 381,995 
Accounts payable and accrued expenses$2,516,908 $2,153,129